Aging, Lifestyle and Inflammation in Veterans Exercising (ALIVE)
Primary Purpose
Inflammation, Aging, Metabolism
Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Weight loss and aerobic exercise training
Sponsored by
About this trial
This is an interventional prevention trial for Inflammation focused on measuring Inflammation, Aging, Metabolism, Exercise
Eligibility Criteria
Inclusion Criteria:
- BMI 20-40 kg/m2
- Waist 80-120cm (men), 70-110cm (women)
- Stable Medical Regimen > or = 30 days
- All women over the age of 50 must be postmenopausal for at least 1 year, have serum FSH >30 mIU/ml, and agree to remain off hormone replacement therapy for the duration of the study
Exclusion Criteria:
- Pregnancy or Nursing Mothers
- Cigarette Smoking
- Diabetes on Medication or Fasting Glucose >126 mg/dl
- Poorly controlled hypertension requiring >3 drugs or beta blockers
- Hyperlipidemia with TG>400mg/dl, LDL>190mg/dl or on Lipitor or Crestor
- Other medications affecting glucose, lipid or cytokine levels
- Thyroid Disease
- Weight gain/loss >5kg in preceding 3 months
- Alcohol >3oz/day
- Caffeine >120 oz/day
- Chronic liver, renal or hematological disease
- Lung disease requiring oxygen
- Active cancer on radiation or chemotherapy treatment
- HIV (+) or other disease prone to malnutrition
- Sickle cell anemia
- Active psychosis or dementia
- Chronic untreated depression
- Hemiparetic Stroke
- Coronary Artery or cerebrovascular disease precluding exercise
- Implantable defibrillator
- Other medical condition precluding exercise testing or participation in exercise and weight loss programs, as per medical judgement of study team
Sites / Locations
- University of Maryland; Baltimore VA Medical Center
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Lifestyle Modification
Arm Description
Combined hypocaloric diet and aerobic exercise training
Outcomes
Primary Outcome Measures
Regional Adipokine Release
Secondary Outcome Measures
Cardiovascular Fitness Body Composition Glucose Tolerance/Insulin Sensitivity
Full Information
NCT ID
NCT00667030
First Posted
April 23, 2008
Last Updated
October 7, 2022
Sponsor
University of Maryland, Baltimore
Collaborators
US Department of Veterans Affairs
1. Study Identification
Unique Protocol Identification Number
NCT00667030
Brief Title
Aging, Lifestyle and Inflammation in Veterans Exercising
Acronym
ALIVE
Official Title
Aging, Lifestyle and Inflammation in Veterans Exercising
Study Type
Interventional
2. Study Status
Record Verification Date
October 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
July 2005 (undefined)
Primary Completion Date
December 2025 (Anticipated)
Study Completion Date
December 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Maryland, Baltimore
Collaborators
US Department of Veterans Affairs
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Over half of adults in this country are overweight. This increases risk for heart and blood pressure problems, cancer, stroke and arthritis. While it is difficult to lose large amounts of weight and keep it off, even small amounts of weight loss can improve health. Furthermore, fat is increasingly recognized as a source of substances that increase inflammation. It may be that some of the adverse consequences of being overweight are due to increased inflammation. We are asking you to volunteer for a research study in which you may lose a moderate amount of weight and increase your activity. It is important that you read and understand the information on this form.
The purposes of these studies are to determine the influence(s) of age and body composition on the production of inflammatory chemicals by fat (adipose tissue), the mechanisms controlling this, and if a weight loss and aerobic exercise intervention results in a decrease in inflammation.
Detailed Description
Adipose tissue is increasingly recognized as more than an inert depot serving not only to accept and store excess energy in the form of triglycerides, but also to secrete hormones and adipokines that have substantial effects on lipid and glucose metabolism. Furthermore, there are depot differences in metabolic function, as well as adipokine content. However, the physiology both underlying and consequential to these observations remains unknown. This research is therefore designed to examine:
1) the effects of aging and obesity on regional adipokine secretion and expression, 2) whether elevated adipokine levels in older obese people are due to increased macrophage infiltration into subcutaneous adipose tissue and/or related to total, subcutaneous or visceral abdominal fat (SAT or VAT) distribution, and 3) the relationship of adipokines to insulin resistance and the constituents of the metabolic syndrome.
Specifically, we aim to determine:
if the expression and secretion of a) the inflammatory markers SAA, IL-6, TNF-a, MCP-1 is greater, and b) the anti-inflammatory hormone adiponectin is lower in SC abdominal and gluteal adipose tissue from older, compared to middle-aged and younger obese subjects across a narrow range of obesity and waist circumference;
if these age-associated changes in adipokine production are a)due to the degree of macrophage infiltration of regional adipose tissue, and/or differences in a greater degree of visceral and/or differences in ABD fat distribution (SAT, VAT), and b) related to glucose and lipid metabolic profiles of the subjects; and
the effects of a WL+AEX intervention on regional adipokine expression and secretion, circulating levels of CRP and the above adipokines, and glucose and lipid metabolism in a subset of obese sedentary individuals with greater than two components of the metabolic syndrome.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Inflammation, Aging, Metabolism, Exercise
Keywords
Inflammation, Aging, Metabolism, Exercise
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Lifestyle Modification
Arm Type
Experimental
Arm Description
Combined hypocaloric diet and aerobic exercise training
Intervention Type
Behavioral
Intervention Name(s)
Weight loss and aerobic exercise training
Intervention Description
Weight loss and aerobic exercise training
Primary Outcome Measure Information:
Title
Regional Adipokine Release
Time Frame
6 month
Secondary Outcome Measure Information:
Title
Cardiovascular Fitness Body Composition Glucose Tolerance/Insulin Sensitivity
Time Frame
6 month
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
BMI 20-40 kg/m2
Waist 80-120cm (men), 70-110cm (women)
Stable Medical Regimen > or = 30 days
All women over the age of 50 must be postmenopausal for at least 1 year, have serum FSH >30 mIU/ml, and agree to remain off hormone replacement therapy for the duration of the study
Exclusion Criteria:
Pregnancy or Nursing Mothers
Cigarette Smoking
Diabetes on Medication or Fasting Glucose >126 mg/dl
Poorly controlled hypertension requiring >3 drugs or beta blockers
Hyperlipidemia with TG>400mg/dl, LDL>190mg/dl or on Lipitor or Crestor
Other medications affecting glucose, lipid or cytokine levels
Thyroid Disease
Weight gain/loss >5kg in preceding 3 months
Alcohol >3oz/day
Caffeine >120 oz/day
Chronic liver, renal or hematological disease
Lung disease requiring oxygen
Active cancer on radiation or chemotherapy treatment
HIV (+) or other disease prone to malnutrition
Sickle cell anemia
Active psychosis or dementia
Chronic untreated depression
Hemiparetic Stroke
Coronary Artery or cerebrovascular disease precluding exercise
Implantable defibrillator
Other medical condition precluding exercise testing or participation in exercise and weight loss programs, as per medical judgement of study team
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jacob B Blumenthal, MD
Organizational Affiliation
Baltimore VA Medical Center, University of Maryland
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Maryland; Baltimore VA Medical Center
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21044
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Aging, Lifestyle and Inflammation in Veterans Exercising
We'll reach out to this number within 24 hrs